742092
Last Update Posted: 2014-03-07
Recruiting has ended
All Genders accepted | 12 Years + |
11 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Miglustat in Cystic Fibrosis
Single Center, Double-Blind, Randomized, Placebo-Controlled, Two-Period/Two-Treatment Crossover Study Investigating the Effect of Miglustat on the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for the F508del Mutation
Eligibility
Relevant conditions:
Cystic Fibrosis
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov